Volume 14 Supplement 1
Validation of dynamic three-dimensional whole heart magnetic resonance myocardial perfusion imaging against single photon emission computed tomography for the detection of functionally significant coronary heart disease
© Jogiya et al; licensee BioMed Central Ltd. 2012
Published: 1 February 2012
We demonstrate the feasibility of 3D myocardial perfusion CMR at 3 Tesla against single photon emission computer tomography for the detection and estimate of ischaemic burden and show good agreement between the techniques. This novel technique shows promising use of this method in a small cohort of patients to estimate ischaemic burden for purpose of risk stratification of patients with known or suspected coronary disease.
The extent and severity of ischaemia on single photon computed tomography (SPECT) is commonly used to risk-stratify patients with suspected coronary artery disease (CAD). Accurate estimates of ischaemia burden by CMR is limited because conventional two-dimensional myocardial perfusion methods cover the heart in a limited number of non-contiguous sections. More recently, three-dimensional (3D) myocardial perfusion CMR has been proposed to overcome the limitation of spatial coverage but has yet to be validated against SPECT.
To compare ischaemia burden on 3D myocardial perfusion CMR with (99m)Tc-tetrofosmin myocardial perfusion SPECT (MPS).
Ten consecutive patients with known or suspected CAD who were clinically referred for MPS underwent 3D CMR perfusion. The 3D datasets were analysed by an experienced observer blinded to the MPS data and images were scored for the presence of inducible ischaemia in accordance to the AHA 17 segment model.
Semi-quantitative analysis of the ischaemic burden was calculated from the sum stress difference between stress and rest tracer uptake for MPS. The 3D CMR perfusion images were similarly analysed for inducible perfusion abnormalities (all areas of hypoperfusion excluding scar on LGE).
3D myocardial perfusion CMR agrees well with SPECT for the detection of coronary artery disease. Both techniques produced similar volumes of ischaemia in the small cohort studied. 3D myocardial perfusion CMR offers a promising alternative method of detecting ischaemia with the added benefits of improved spatial resolution and avoiding the need for ionising radiation. The method holds promise for the risk stratification of patients with known or suspected CAD.
SP is funded by British Heart Foundation fellowship FS/10/62/28409.
SP/EN receives research grant support from Philips Healthcare.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.